The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.
Acute subarachnoid hemorrhage
Age greater than 18 years
Secured aneurysm
Patient can verbalize pain score to clinician, nurse, medical translator, or surrogate decision
Less than 18 years old
Unsecured aneurysm
Pregnant or lactating
Prisoner
University of California, Davis
Lead sponsor
Agnes Marshall Walker Foundation
Collaborator